Standard Biotools (LAB) Income towards Parent Company (2010 - 2026)

Standard Biotools (LAB) has reported Income towards Parent Company for 17 consecutive years, with -$26.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Income towards Parent Company fell 51.46% year-over-year to -$26.8 million in Q2 2026; TTM through Jun 2026 was $82.5 million, a 188.92% increase from a year earlier, with the FY2025 full-year figure at -$58.8 million, up 57.05% from the prior year.
• Income towards Parent Company was -$26.8 million for Q2 2026 at Standard Biotools, down from $127.1 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $127.1 million in Q1 2026 and troughed at -$76.3 million in Q1 2022.
• A 5-year average of -$17.6 million and a median of -$23.7 million in 2024 frame the typical range for Income towards Parent Company.
• Across the five-year window, Income towards Parent Company slumped 626.36% in 2024 and jumped 588.1% in 2026, its largest moves.
• Over 5 years, Income towards Parent Company stood at -$20.8 million in 2022, then jumped by 82.05% to -$3.7 million in 2023, then tumbled by 626.36% to -$27.2 million in 2024, then surged by 151.16% to $13.9 million in 2025, then slumped by 292.56% to -$26.8 million in 2026.
• The last three Income towards Parent Company figures came in at -$26.8 million (Q2 2026), $127.1 million (Q1 2026), and $13.9 million (Q4 2025), per Business Quant data.